• 2025.07.03Timely Disclosure
  Announcement of completion of patient registration in a Phase II study of nivolumab and PAI(201KB)
• 2025.06.20Timely Disclosure
  Announce Completion of Patient Enrollment for Cutaneous Angiosarcoma Treatment(155KB)
• 2025.06.02Timely Disclosure
  Notice of termination of joint research agreement with Daiichi Sankyo Co., Ltd. regarding novel coronavirus pneumonia and other lung injuries.(142KB)
• 2025.05.26Timely Disclosure
  Notice of Change of Representative Director and Directors(160KB)
• 2025.05.26Timely Disclosure
  Notice of partial amendment to the Articles of Incorporation(217KB)

IR News List